253 related articles for article (PubMed ID: 32000564)
1. Evaluating liquid biopsies for methylomic profiling of prostate cancer.
Silva R; Moran B; Russell NM; Fahey C; Vlajnic T; Manecksha RP; Finn SP; Brennan DJ; Gallagher WM; Perry AS
Epigenetics; 2020; 15(6-7):715-727. PubMed ID: 32000564
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer.
Silva R; Moran B; Baird AM; O'Rourke CJ; Finn SP; McDermott R; Watson W; Gallagher WM; Brennan DJ; Perry AS
Clin Epigenetics; 2021 Aug; 13(1):168. PubMed ID: 34454584
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation signatures of Prostate Cancer in peripheral T-cells.
Mehdi A; Cheishvili D; Arakelian A; Bismar TA; Szyf M; Rabbani SA
BMC Cancer; 2020 Jun; 20(1):588. PubMed ID: 32576165
[TBL] [Abstract][Full Text] [Related]
4. A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA.
Brikun I; Nusskern D; Decatus A; Harvey E; Li L; Freije D
Clin Epigenetics; 2018; 10():91. PubMed ID: 29988684
[TBL] [Abstract][Full Text] [Related]
5. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
6. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
7. Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection.
Jarrard WE; Schultz A; Etheridge T; Damodaran S; Allen GO; Jarrard D; Yang B
PLoS One; 2019; 14(6):e0218950. PubMed ID: 31233548
[TBL] [Abstract][Full Text] [Related]
8. Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients.
Moreira-Barbosa C; Barros-Silva D; Costa-Pinheiro P; Torres-Ferreira J; Constâncio V; Freitas R; Oliveira J; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2018 Oct; 10(1):132. PubMed ID: 30373654
[TBL] [Abstract][Full Text] [Related]
9. Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery.
Lee B; Mahmud I; Marchica J; Dereziński P; Qi F; Wang F; Joshi P; Valerio F; Rivera I; Patel V; Pavlovich CP; Garrett TJ; Schroth GP; Sun Y; Perera RJ
Sci Rep; 2020 Feb; 10(1):3716. PubMed ID: 32111915
[TBL] [Abstract][Full Text] [Related]
10. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of emerging liquid biomarkers in advanced prostate cancer.
Vandekerkhove G; Chi KN; Wyatt AW
Cancer Genet; 2018 Dec; 228-229():151-158. PubMed ID: 28958406
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric liquid biopsy analysis in metastatic prostate cancer.
Hodara E; Morrison G; Cunha A; Zainfeld D; Xu T; Xu Y; Dempsey PW; Pagano PC; Bischoff F; Khurana A; Koo S; Ting M; Cotter PD; Moore MW; Gunn S; Usher J; Rabizadeh S; Danenberg P; Danenberg K; Carpten J; Dorff T; Quinn D; Goldkorn A
JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30702443
[TBL] [Abstract][Full Text] [Related]
13. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
Vandekerkhove G; Struss WJ; Annala M; Kallio HML; Khalaf D; Warner EW; Herberts C; Ritch E; Beja K; Loktionova Y; Hurtado-Coll A; Fazli L; So A; Black PC; Nykter M; Tammela T; Chi KN; Gleave ME; Wyatt AW
Eur Urol; 2019 Apr; 75(4):667-675. PubMed ID: 30638634
[TBL] [Abstract][Full Text] [Related]
14. Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer.
Daniūnaitė K; Berezniakovas A; Jankevičius F; Laurinavičius A; Lazutka JR; Jarmalaitė S
Medicina (Kaunas); 2011; 47(3):147-53. PubMed ID: 21822036
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential.
Bjerre MT; Nørgaard M; Larsen OH; Jensen SØ; Strand SH; Østergren P; Fode M; Fredsøe J; Ulhøi BP; Mortensen MM; Jensen JB; Borre M; Sørensen KD
Cells; 2020 May; 9(6):. PubMed ID: 32486483
[TBL] [Abstract][Full Text] [Related]
16. Development of a multivariable risk model integrating urinary cell DNA methylation and cell-free RNA data for the detection of significant prostate cancer.
Connell SP; O'Reilly E; Tuzova A; Webb M; Hurst R; Mills R; Zhao F; Bapat B; Cooper CS; Perry AS; Clark J; Brewer DS
Prostate; 2020 May; 80(7):547-558. PubMed ID: 32153047
[TBL] [Abstract][Full Text] [Related]
17. Epigenome-Wide Association Study of Prostate Cancer in African Americans Identifies DNA Methylation Biomarkers for Aggressive Disease.
Xu Y; Tsai CW; Chang WS; Han Y; Huang M; Pettaway CA; Bau DT; Gu J
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944472
[TBL] [Abstract][Full Text] [Related]
18. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
Morrison GJ; Goldkorn A
Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
[TBL] [Abstract][Full Text] [Related]
19. Using circulating cell-free DNA to monitor personalized cancer therapy.
Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
[TBL] [Abstract][Full Text] [Related]
20. Urinary DNA Methylation Biomarkers for Noninvasive Prediction of Aggressive Disease in Patients with Prostate Cancer on Active Surveillance.
Zhao F; Olkhov-Mitsel E; van der Kwast T; Sykes J; Zdravic D; Venkateswaran V; Zlotta AR; Loblaw A; Fleshner NE; Klotz L; Vesprini D; Bapat B
J Urol; 2017 Feb; 197(2):335-341. PubMed ID: 27545574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
